With flexible GMP facilities and experienced teams, we support API commercialisation through optimised process demonstrations and validation batches, ensuring successful regulatory submissions.

What we offer

eurofins-cdmo-alphora_process-validation_impurity-control

Spike, fate and purge studies

Eurofins CDMO provides impurity control strategies from IND to commercial stages. With a proven track record in impurity fate and purge studies, we analyse the origin, clearance, and fate of impurities to meet client requirements.

adobestock_403448452 (2)

Impurity synthesis

We provide comprehensive services throughout the development process, specialising in impurity synthesis and control. We identify, isolate and synthesise process-related impurities to support development, analytical controls and regulatory requirements.

adobestock_530573975 (1)

Commercialisation support

Provided as part of an existing programme or a stand-alone service, our commercialisation support encompasses optimised process demonstration, Design of Experiments (DoE), critical process parameters studies including Quality by Design (QbD) and technology transfer to client’s API CMO, as applicable and continuous CMC support during and after market launch. We also prepare and execute process validation batches and commercial re-supply up to 1kg.

adobestock_528567825-1

Let's advance your innovation together